Y-mAbs Therapeutics
YMAB
YMAB
91 hedge funds and large institutions have $93.6M invested in Y-mAbs Therapeutics in 2022 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 25 increasing their positions, 33 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
91
Holders Change
-9
Holders Change %
-9%
% of All Funds
1.47%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
20
Increased
25
Reduced
33
Closed
29
Calls
$92K
Puts
–
Net Calls
+$92K
Net Calls Change
-$1.69M
Top Buyers
| 1 |
1
Millennium Management
New York
|
$5.51M |
| 2 |
2
Citadel Advisors
Miami,
Florida
|
$4.69M |
| 3 |
3
AQR Capital Management
Greenwich,
Connecticut
|
$2.34M |
| 4 |
4
Point72 Asset Management
Stamford,
Connecticut
|
$2.19M |
| 5 |
5
D.E. Shaw & Co
New York
|
$2.29M |
